<?xml version="1.0" encoding="UTF-8"?>
<p id="par0045">Although there is little reported data indicating the minimal inhibitory concentration of acyclovir treatment for disseminated varicella infection in immunocompromised patients, the drug plasma concentration after intravenous acyclovir (5 mg/kg every eight hours) is around ten times higher than oral acyclovir use (multiple doses of 400 mg) and is documented as the standard treatment of serious infection in immunocompromised hosts [
 <xref rid="bib0045" ref-type="bibr">9</xref>]. The administration of oral famciclovir treatment in immunocompromised patients with disseminated cutaneous and visceral involvement is not the standard of care.
</p>
